Publisher
Springer Science and Business Media LLC
Reference28 articles.
1. Lee C, Kim HN, Kwon JA, Yoon S-Y, Jeon MJ, Yu ES, et al. Implications of the 5th edition of the world health organization classification and international consensus classification of myeloid neoplasm in myelodysplastic syndrome with excess blasts and acute myeloid leukemia. Ann Lab Med. 2023;43:503–7.
2. Khoury JD, Solary E, Abla O, Akkari Y, Alaggio R, Apperley JF, et al. The 5th edition of the world health organization classification of haematolymphoid tumours: myeloid and histiocytic/dendritic neoplasms. Leukemia. 2022;36:1703–19.
3. Dotson JL, Lebowicz Y. Myelodysplastic syndrome. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 [cited 2024 Feb 11]. http://www.ncbi.nlm.nih.gov/books/NBK534126/.
4. Lauritsen TB, Nørgaard JM, Dalton SO, Grønbæk K, El-Galaly TC, Østgård LSG. 10-year nationwide trends in incidence, treatment patterns, and mortality of patients with myelodysplastic syndromes in Denmark. Leuk Res. 2023;128:107056.
5. Kontro S, Raitanen J, Porkka K, Auvinen A. Incidence of myelodysplastic syndromes in Finland 1997–2016. Leuk Res. 2022;116:106839.